Peer-reviewed Articles 2012

  • Decressac M., Pain S., Chabeauti PY., Frangeul L., Thiriet N., Herzog H., Vergote J., Chalon S., Jaber M, Gaillard A. (2012). “Neuroprotection by neuropeptide Y in cell and animal models of Parkinson’s disease”. Neurobiol. Aging, 33, 2125-2137
  • Saha B, Jaber M, Gaillard A. Potentials of endogenous neural stem cells in cortical repair. Front Cell Neurosci. 2012 Apr 9;6:14.
  • Gely-Pernot A, Coronas V, Harnois T, Prestoz L, Mandairon N, Didier A, Berjeaud JM, Monvoisin A, Bourmeyster N, De Frutos PG, Philippe M, Benzakour O. “An endogenous vitamin K-dependent mechanism regulates cell proliferation in the brain subventricular stem cell niche.” Stem Cells. 2012, 30(4):719-731
  • Villalva C, Cortes U, Wager M, Tourani JM, Rivet P, Marquant C, Martin S, Turhan AG, Karayan-Tapon L. “O6-Methylguanine-methyltransferase (MGMT) promoter methylation status in glioma stem-like cells is correlated to temozolomide sensitivity under differentiation-promoting conditions.” Int J Mol Sci. 2012;13(6):6983-94.
  • Quillien V, Lavenu A, Karayan-Tapon L., et al. (2012) “Comparative assessment of 5 methods (methylationspecific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 glioblastoma patients.” Cancer. 1;118(17):4201-11
  • Liu P, Brown S, Goktug T, Channathodiyil P, Kannappan V, Hugnot JP, Guichet PO, Bian X, Armesilla AL, Darling JL, Wang W. Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDHpositive cancer-stem-like cells. British journal of cancer. 2012;107(9):1488-97.
  • Decressac M, Pain S, Chabeauti PY, Frangeul L, Thiriet N, Herzog H, Vergote J, Chalon S, Jaber M, Gaillard A ≪ Neuroprotection by neuropeptide Y in cell and animal models of Parkinson’s disease ≫ Neurobioly of Aging 2012 Sep : 33(9)2125-37
  • De Luca MA, Solinas M, Bimpisidis Z, Goldberg SR, Di Chiara G. ≪ Cannabinoid facilitation of behavioral and biochemical hedonic taste responses. ≫ Neuropharmacology. 2012 Jul;63(1):161-8.
  • Chauvet C, Goldberg SR, Jaber M, Solinas M. ≪ Effects of environmental enrichment on the incubation of cocaine craving. ≫ Neuropharmacology. 2012 Sep;63(4):635-41.
  • Nader J, Chauvet C, Rawas RE, Favot L, Jaber M, Thiriet N, Solinas M ≪ Loss of environmental enrichment increases vulnerability to cocaine addiction ≫ Neuropsychopharmacology 2012 Jun ;37(7) : 1579-87
  • Lemaire V, Tronel S, Montaron MF, Fabre A, Dugast E, Abrous DN ≪ long-lasting plasticity of hippocampal adult-born neurons ≫ Journal of neurosciences 2012 Feb 29 :32(9) :3101-8
  • Couturier J, Paccalin M, Lafay-Chebassier C, Chalon S, Ingrand I, Pinguet J, Pontcharraud R, Guillard O, Fauconneau B, Page G. ≪ Pharmacological inhibition of PKR in APPswePS1dE9 mice transiently prevents inflammation at 12 months of age but increases Aβ42 levels in the late stages of the Alzheimer’s disease. ≫ Curr Alzheimer Res. 2012 Mar;9(3):344-60.
  • Nader J, El Rawas R, Chauvet C, Jaber M, Thiriet N, Solinas M. Loss of environmental enrichment increases vulnerability to cocaine addiction. Neuropsychopharmacology. 2012; 37(7): 1579-87.
  • Decressac M, Pain S, Chabeauti P-Y, Frangeul L, Thiriet N, Herzog H, Vergote J, Chalon S, Jaber M, Gaillard A. Neuroprotection by neuropeptide Y in cell and animal models of Parkinson’s disease. Neurobiol Aging. 2012; 33(9): 2125–37.
  • Chauvet C, Goldberg S R, Jaber M, Solinas M. Effects of environmental enrichment on the incubation of cocaine craving. Neuropharmacology. 2012; 63(4): 635-41.
  • Fernagut PO, Vital A, Canron MH, Tison F, Meissner WG: Ambiguous mechanisms of dysphagia in
    multiple system atrophy. Brain 2012; 135: e205; author reply e206
  • Pédeboscq S, Gravier D, Casadebaig F, Hou G, Gissot A, Rey C, Ichas F, De Giorgi F, Lartigue L, Pometan JP. « Synthesis and evaluation of apoptosis induction of thienopyrimidine compounds on KRAS and BRAF mutated colorectal cancer cell lines. » Bioorg Med Chem. 2012 Nov 15;20(22):6724-31.
  • Pédeboscq S, Rey C, Petit M, Harpey C, De Giorgi F, Ichas F, Lartigue L. « Non-antioxidant properties of α-tocopherol reduce the anticancer activity of several protein kinase inhibitors in vitro. » PLoS One. 2012;7(5):e36811.
  • Auzanneau C, Montaudon D, Jacquet R, Puyo S, Pouységu L, Deffieux D, Elkaoukabi-Chaibi A, De Giorgi F, Ichas F, Quideau S, Pourquier P. « The polyphenolic ellagitannin vescalagin acts as a preferential catalytic inhibitor of the α isoform of human DNA topoisomerase II. » Mol Pharmacol. 2012 Jul;82(1):134-41.

Recherche

Menu principal

Haut de page